Eur. J. Nucl. Med. Mol. Imaging 2020 Jan 24
Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience.
Kunikowska J, Zemczak A, Kolodziej M, Gut P, Lon I, Pawlak D, Mikolajczak R, Kaminski G, Ruchala M, Kos-Kudla B, Królicki L
One of the concepts of theranostics in nuclear medicine is peptide receptor radionuclide therapy (PRRT), whereby labeled somatostatin analogs are used ...
Read More
Source: PubMed
Medicine (Baltimore)
Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
Naglieri E, Niccoli Asabella A, Nappi AG, Carella C, Ferrari C, Rubini G
Papillary renal cell carcinoma (PRCC) accounts for about 15% to 20% of renal cell carcinoma and is histologically distinguished in type I and type II. ...
Read More
Source: PubMed
Semin Nucl Med
Radionuclide Tools in Clinical Management of Febrile UTI in Children.
De Palma D
The optimal imaging strategy for febrile urinary tract infections in children is not yet satisfactorily defined, mainly because of the different clini ...
Read More
Source: PubMed
